Colgate-Palmolive (NYSE:CL) Cut to Hold at StockNews.com

StockNews.com cut shares of Colgate-Palmolive (NYSE:CL) from a buy rating to a hold rating in a research note published on Friday.

Several other equities analysts also recently commented on CL. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Piper Sandler lowered their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. Raymond James reissued an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Finally, Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $89.80 on Friday. The firm has a 50 day moving average of $89.02 and a 200 day moving average of $94.67. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $72.87 billion, a price-to-earnings ratio of 25.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business earned $0.87 earnings per share. On average, research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Institutional Trading of Colgate-Palmolive

A number of institutional investors have recently modified their holdings of the company. Northstar Financial Companies Inc. bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $331,000. Mattson Financial Services LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $264,000. Wood Tarver Financial Group LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $48,000. GHE LLC boosted its holdings in shares of Colgate-Palmolive by 1.7% in the 4th quarter. GHE LLC now owns 21,288 shares of the company’s stock valued at $1,935,000 after buying an additional 350 shares in the last quarter. Finally, Menard Financial Group LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $102,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.